Medical crowdfunding is commonplace and unsustainable

"Crowdfunding is really replicating the sort of status quo and the existing inequities that shaped so much of social and economic life in the U.S."

May 20, 2024 Check out STAT+

Sponsored By

Adobe STAT+ | Medical crowdfunding isn't a solution for skyrocketing health care costs U.S. health care is too costly, and crowdsourcing care amplifies inequities in who accumulates medical debt, Nora Kenworthy says in new book "Crowded Out." By Annalisa Merelli STAT+ | Class action against UnitedHealth asks about DOJ probe transparency Class action lawsuit alleges UnitedHealth misled investors when it didn't disclose a Department of Justice investigation. By Bob Herman STAT+ | PBM executives invited to testify before House panel Executives at the three major pharmacy benefit manager companies have been invited to testify before a House committee next month. By Rachel Cohrs Zhang Sarah Gonzalez for STAT STAT+ | AI & drug discovery: A biotech CEO, a scientist, and a venture capitalist separate hype from reality AI can help advance drug development. During STAT Breakthrough Summit in San Francisco, experts talked about what's realistic and what's hype. By Casey Ross and Matthew Herper STAT+ | A novel spinal cord stimulator treats paralysis without surgery. FDA will rule on it soon Results from clinical trial found Onward Medical's non-invasive spinal cord stimulator improved hand and arm function in 72% of participants. By Lizzy Lawrence and Timmy Broderick Boehringer takes the reins on inhaler costs while navigating a complex drug pricing environment The U.S. healthcare industry is ever evolving, and there is one thing everyone agrees on: it's complex and often challenging for patients, especially those most vulnerable. One of the complexities that impacts the daily lives of many Americans is the high costs of necessary life-saving treatments. An example of this is for treatments of respiratory illnesses, such as COPD and asthma, which depend on patients being able to access the medications they need. In recent years, access to the inhalers that treat these conditions has become increasingly difficult due to high prices forcing underinsured and uninsured populations to choose between prioritizing basic everyday expenses like paying rent and treating their respiratory illness. By Karissa McCarthy Kevin Dietsch/Getty Images STAT+ | Bernie Sanders may have reached the limits of his pharma pressure campaign Sen. Bernie Sanders is testing the limits of the powers of a Senate chairman with little hope of advancing his policy agenda legislatively. By Rachel Cohrs Zhang

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Daily Recap? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2024, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser